RadNet: Imaging And AI Keep The Bull Case Intact

Impact · against what's priced in

The article reinforces the bull case for RDNT through revenue quality improvements and software diversification. With no contradictory pricing assumptions, the expansion of the advanced imaging mix and DeepHealth's dual-track growth represent positive catalysts for margin expansion.

RDNT+0.60

No priced-in read yet

In context

The shift toward an advanced imaging mix and the dual-track growth of DeepHealth through external sales and internal efficiency provide a clear path to margin expansion and scalable revenue.

Read from the article alone

• revenue growth
• RDNT
• healthcare tech
• margins
• medical imaging
• software sales
• workflow automation

Search tags